Evaluation of antipsychotic information on UK schizophrenia websites

Akram, G. and Boyter, A.C. and Thomson, A.H. (2010) Evaluation of antipsychotic information on UK schizophrenia websites. Psychiatrist, 34 (10). pp. 422-426.

Full text not available in this repository.Request a copy from the Strathclyde author

Abstract

The aim and methods of this paper are to evaluate the quality of information about medication on 33 UK schizophrenia websites using a bespoke tool known as the Strathclyde Website Evaluation Form (SWEF). The mean total SWEF score was 26 out of a maximum of 52. For website content, the mean score was 15.3 out of a maximum of 32. Most websites mentioned antipsychotics (n = 23), but only 10 described the differences between typical and atypical classes. Three websites mentioned the different injectable formulations. Information about side-effects, particularly from atypicals was limited. Comprehensive details about clozapine including the blood monitoring requirements were found on two websites. Currency was reasonable with 20 websites being less than 3 years old. Information about antipsychotic medication on UK schizophrenia websites is basic and incomplete.